Remarkable response to CDK4/6 inhibitor-based endocrine therapy in HR+/HER2- metastatic male breast cancer with visceral crisis: a case report. [PDF]
Liu J, Chen W, Wang J, Wang X.
europepmc +1 more source
Ki67 Expression and Its Association With Clinicopathological Factors and Intrinsic Subtypes of Male Breast Cancer in Uganda: A Cross-sectional Study. [PDF]
Okecha T +7 more
europepmc +1 more source
Current Perspectives on Non-Metastatic Male Breast Cancer: Genetics, Biology, and Treatment Advances: A Systematic Review. [PDF]
Melan K, Loap P, Kirova Y.
europepmc +1 more source
Evaluation of serum alkaline phosphatase and lactate dehydrogenase as predictive biomarkers for the prognosis of male breast cancer. [PDF]
Kong X +9 more
europepmc +1 more source
Commentary and Updates on the Management of Male Breast Cancer. [PDF]
van den Bruele AB +3 more
europepmc +1 more source
Clinical Characteristics and Survival Trends of Male Breast Cancer in the United States: A Propensity Score Matched Analysis. [PDF]
Krishnan J +3 more
europepmc +1 more source
CHEK2 1100delC and male breast cancer in the Netherlands
Marijke Wasielewski +8 more
openalex +2 more sources
Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG). [PDF]
Arslan ÜY +12 more
europepmc +1 more source

